GA
Geneva Advisors’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q2 | $3.69M | Sell |
50,853
-274
| -0.5% | -$19.9K | 0.06% | 139 |
|
2017
Q1 | $3.33M | Sell |
51,127
-28,015
| -35% | -$1.83M | 0.06% | 155 |
|
2016
Q4 | $4.96M | Sell |
79,142
-7,100
| -8% | -$445K | 0.1% | 118 |
|
2016
Q3 | $5.44M | Buy |
86,242
+10,122
| +13% | +$638K | 0.1% | 117 |
|
2016
Q2 | $4.71M | Sell |
76,120
-545,118
| -88% | -$33.8M | 0.09% | 119 |
|
2016
Q1 | $35.5M | Buy |
621,238
+1,289
| +0.2% | +$73.6K | 0.71% | 54 |
|
2015
Q4 | $36.7M | Buy |
619,949
+853
| +0.1% | +$50.5K | 0.71% | 50 |
|
2015
Q3 | $33.7M | Sell |
619,096
-262,307
| -30% | -$14.3M | 0.68% | 49 |
|
2015
Q2 | $59.2M | Buy |
881,403
+3,998
| +0.5% | +$269K | 1.06% | 37 |
|
2015
Q1 | $51.4M | Sell |
877,405
-338,828
| -28% | -$19.8M | 0.93% | 38 |
|
2014
Q4 | $79.6M | Buy |
1,216,233
+107,520
| +10% | +$7.04M | 1.48% | 16 |
|
2014
Q3 | $64M | Buy |
1,108,713
+1,055,835
| +1,997% | +$61M | 1.21% | 26 |
|
2014
Q2 | $2.98M | Buy |
52,878
+10,654
| +25% | +$601K | 0.05% | 173 |
|
2014
Q1 | $2.17M | Buy |
42,224
+20,808
| +97% | +$1.07M | 0.04% | 198 |
|
2013
Q4 | $1.13M | Buy |
21,416
+140
| +0.7% | +$7.39K | 0.02% | 243 |
|
2013
Q3 | $952K | Sell |
21,276
-2,088
| -9% | -$93.4K | 0.02% | 255 |
|
2013
Q2 | $966K | Buy |
+23,364
| New | +$966K | 0.02% | 223 |
|